Prelude Therapeutics Inc at H C Wainwright Precision Oncology Conference (Virtual) Transcript
For our next fireside chat, I am joined by Dr. Kris Vaddi, the CEO of Prelude Therapeutics. Dr. Vaddi, thank you for joining us today.
Thank you. Thank you for the invitation to join.
Questions & Answers
Well, I certainly look forward to a lively discussion especially with all the data sets that were recently released at the triple meeting. But before we get into the pipeline and all the data that was released, for those who may be new to the Prelude story, can you provide a brief high-level overview of Prelude's discovery and development approach, as well as the pipeline that you've developed around that approach?
Yes, absolutely. For those of you who are new to Prelude's story, we are recently public. About a year ago, we went public, but we are a five-year-old company that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |